Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

January 31, 2024
IgE and High Affinity IgE Receptor in Chronic Inducible Urticaria, pathogenic and man...
Ana Giménez Arnau, Clara Ribas-Llauradó, Nasser Mohammad-Porras, et al.
January 31, 2024
Urticaria Patients Are Highly Interested in Apps to Monitor Their Disease Activity an...
Ivan Cherrez-Ojeda, Emanuel Vanegas, Annia Cherrez, et al.
November 13, 2023
INFLAMMATORY CYTOKINE LEVELS AND CHANGES DURING OMALIZUMAB TREATMENT IN CHRONIC SPONT...
Selcen Hoşgören-Tekin, İrem Peker Eyüboğlu, Mustafa Akkiprik, et al.
October 13, 2021
Low and high IgE is linked to improvement and worsening of chronic urticaria during p...
Emek Kocatürk, Simon Francis Thomsen, Mona Al-Ahmad , et al.
July 22, 2020
Practice Parameters for Diagnosing and Managing Iodinated Contrast Media Hypersensiti...
María José Torres, Axel Trautmann, Ingrid Böhm, et al.
July 08, 2020
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systemat...
Ioana Agache, Yang Song, Margarita Posso, et al.
July 08, 2020
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria- a...
Ioana Agache, Claudio Rocha, Yang Song, et al.